Patents by Inventor Giuseppe Nunnari

Giuseppe Nunnari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cellular Targets for Treatment of Retroviral Infection
    Publication number: 20110086423
    Abstract: Cellular targets for anti-retroviral drug development are disclosed. The cellular targets comprise ATR kinase and its relevant substrates, based on the identification of the ATR kinase as required for the final step of retroviral DNA integration. Assays for identifying modulators of retroviral integration via the ATR kinase pathway are disclosed, as well as modulators identified by such assays. Pharmaceutical preparations and methods of their use in treating retroviral infection are also disclosed.
    Type: Application
    Filed: June 14, 2010
    Publication date: April 14, 2011
    Inventors: Rene Daniel, Anna Marie Skalka, Gary D. Kao, Giuseppe Nunnari, Roger J. Pomerantz
  • Cellular targets for treatment of retroviral infection
    Patent number: 7736848
    Abstract: Cellular targets for anti-retroviral drug development are disclosed. The cellular targets comprise ATR kinase and its relevant substrates, based on the identification of the ATR kinase as required for the final step of retroviral DNA integration. Assays for identifying modulators of retroviral integration via the ATR kinase pathway are disclosed, as well as modulators identified by such assays. Pharmaceutical preparations and methods of their use in treating retroviral infection are also disclosed.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: June 15, 2010
    Assignee: Fox Chase Cancer Center
    Inventors: Rene Daniel, Anna Marie Skalka, Gary D. Kao, Giuseppe Nunnari, Roger J. Pomerantz